Search Results - "Youdim MBH"

Artificial intelligence and machine learning based discovery of bioisosteres (BIOS) of FDA approved MAO-B inhibitors for the management of Alzheimer's disease.

Authors: Kumar, Akshay Jaiswal, Sanjana Parmar, Shaili Singh et al.

Source: Discover Chemistry. 4/1/2026, Vol. 3 Issue 1, p1-19. 19p.

Research Progress on the Mechanism of Polygonatum sibiricum in the Prevention and Treatment of Neurodegenerative Diseases.

Authors: Tang, Huiyang Chen, Xinlu Wang, Shanshan et al.

Source: Natural Product Communications. Mar2026, Vol. 21 Issue 3, p1-13. 13p.

Monocytic TLR4 expression and activation in schizophrenia: A systematic review and meta-analysis.

Authors: Jameie, Melika Bordbar, Sanaz Samiee, Reza et al.

Source: PLoS ONE. 3/28/2025, Vol. 20 Issue 3, p1-23. 23p.

Activity assays for flavoprotein oxidases: an overview.

Authors: Santema, Lars L. Fraaije, Marco W.

Source: Applied Microbiology & Biotechnology; 5/8/2025, Vol. 109 Issue 1, p1-22, 22p

Hypoxia-Inducible Factor 1-alpha (HIF1α), Nicotinamide Adenine Dinucleotide (NAD+, NADH), and Nitric Oxide (NO) interplay in critically ill patients, with implications for patient safety and targeted therapies: a review.

Authors: Bar-Or, David Banton, Kaysie Acuna, David et al.

Source: Patient Safety in Surgery. 10/27/2025, Vol. 19 Issue 1, p1-12. 12p.

Association of SCN2A single nucleotide polymorphisms with Parkinson's disease: evidence from a case-control study.

Authors: Li, Teng Wang, Jingxin Gao, Gan et al.

Source: International Journal of Neuroscience. Oct2025, Vol. 135 Issue 10, p1163-1171. 9p.

Subjects: Parkinson's disease, Single nucleotide polymorphisms, Case-control method, Gene expression, Genetic correlations, Sodium channels

Association between iron profile and negative symptoms in first-episode schizophrenia spectrum disorder: a cross-sectional study.

Authors: Raj, Rajnish Nazir, Deeba Wani, Zaid Ahmad et al.

Source: Middle East Current Psychiatry. 9/5/2025, Vol. 32 Issue 1, p1-7. 7p.

Coumarin derivative-functionalized nanoporous silica as an on–off fluorescent sensor for detecting Fe3+ and Hg2+ ions: a circuit logic gate.

Authors: Mousavi, Zahra Ghasemi, Jahan B. Mohammadi Ziarani, Ghodsi et al.

Source: Discover Nano; 4/22/2024, Vol. 19 Issue 1, p1-13, 13p

Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures.

Authors: Fedorov, Vladimir N. Korsakov, Mikhail K. Shetnev, Anton A. et al.

Source: Research Results in Pharmacology. 2024, Vol. 10 Issue 4, p129-135. 7p.

IN SILICO and IN VITRO Estimation of MAO-B Inhibitory Activity of Newly Synthesized Hydrazones Bearing a Pyrrole Heterocyclic System.

Authors: Tzankova, Diana Mateev, Emilio Vladimirova, Stanislava et al.

Source: Pharmaceutical Chemistry Journal. Dec2023, Vol. 57 Issue 9, p1444-1448. 5p.

Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders.

Authors: Kuan, Jun Han Raghavan, Roshan S. Koh, Dawn Li Wei et al.

Source: Neuroprotection. Mar2026, Vol. 4 Issue 1, p30-47. 18p.

Interconnected Pathways of Alzheimer's Disease and Osteoporosis: A Review of Genetic, Hormonal, and Environmental Influences.

Authors: Li, Yu-Xin Liu, Kun Zeng, Qin et al.

Source: Aging & Disease. Feb2026, Vol. 17 Issue 1, p159-184. 26p.

Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease.

Authors: Abdul‐Rahman, Toufik Awuah, Wireko Andrew Mikhailova, Tatiana et al.

Source: Biofactors. Jul2024, Vol. 50 Issue 4, p693-708. 16p.

Fluorescent probe based on hydrogel-immobilized carbon dots complex with temperature-trigger for ferric iron detection.

Authors: Lin, Haitao Jiang, Zike Wang, Jing et al.

Source: Journal of Materials Science; May2023, Vol. 58 Issue 18, p7602-7612, 11p, 2 Diagrams, 1 Chart, 4 Graphs

Oxytetracycline and its Non-Antibiotic Derivative DOT Protect Midbrain Dopamine Neurons from Iron-Driven Oxidative Damage.

Authors: Alves Fernandes, Thaís Antonia Tourville, Aurore Ciss, Ismaila et al.

Source: Neurotoxicity Research. Apr2025, Vol. 43 Issue 2, p1-16. 16p.

Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.

Authors: Wang, Changyong Lv, Shanyu Zhao, Hongyan et al.

Source: Neurological Sciences. Mar2025, Vol. 46 Issue 3, p1111-1120. 10p.

Subjects: Parkinson's disease, Cerebral anoxia, Medical sciences, Iron metabolism, Iron chelates

Nose-to-brain delivery of microcarrier in the treatment of neurodegenerative diseases.

Authors: Pandey, Saurav Nainwal, Nidhi Negi, Teena et al.

Source: Journal of Applied Pharmaceutical Science. Mar2025, Vol. 15 Issue 3, p22-29. 8p.

Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia.

Authors: Delaby, Constance Alcolea, Daniel Busto, Germain et al.

Source: Alzheimer's Research & Therapy. 2/13/2025, Vol. 17 Issue 1, p1-12. 12p.

CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease models.

Authors: Leser, Felipe Saceanu Júnyor, Flavio de Souza Pagnoncelli, Iohanna Bianca et al.

Source: Journal of Neuroinflammation. 2/2/2025, Vol. 22 Issue 1, p1-23. 23p.

Parkinson's disease: pathogenesis and therapeutic strategies.

Authors: Zhang S Wang T Peng Y et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Apr 08; Vol. 7 (1). Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE